← Evidence map

ArticleTranslational andrology and urology2017

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

Olivier CuvillierPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28217462